European Journal of Heart Failure

Titel Veröffentlichungsdatum Sprache Zitate
Un(b)locking therapeutic options: Potential for calcium channel blockers in heart failure with non‐reduced left ventricular ejection fraction2023/11/15English
Physician perceptions, attitudes, and strategies towards implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice2024/03/22English
Reply to ‘Breaking down peripartum cardiomyopathy: A learning adventure’2024/03/21English
The pharmacist ally in heart failure: Useful when involved. Letter regarding the article ‘Effective medications can work only in patients who take them: Implications for post‐acute heart failure care’2024/03/25English
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort2024/03/25English
Cost‐effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA‐HF and DELIVER data2024/03/20English
Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension2024/03/13English
Dissecting the heart failure phenotype through phenomics2024/03/19English
Moving theory and reality closer together in cardio‐oncology training2024/03/20English
Renal perturbations with sodium–glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction2024/03/19English
The salt paradox in heart failure2024/03/11English
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER2024/03/15English
More than just a clinical syndrome: Biomarkers and echocardiography should be rapidly advised for anyone with suspected heart failure!2024/03/27English
Temporary mechanical circulatory support for cardiogenic shock: Definitive intervention or ancillary bridging therapy? Letter regarding the article ‘What about current recommendations for extracorporeal life support in acute myocardial infarction‐associated cardiogenic shock: Stay or go? or time to revise?’2024/03/26English
Issue Information2024/02/01English
Pre‐diagnostic free androgen and estradiol levels influence heart failure risk in both women and men: A prospective cohort study in the UK Biobank2024/03/25English
Global longitudinal strain as a predictor of risk in patients with heart failure with preserved ejection fraction: A deserved role?2024/03/25English
Discovering altered genomic expression patterns in heart: transcriptome determination by serial analysis of gene expression2001/06/01English
Different baseline sympathovagal balance and cardiac autonomic responsiveness in ischemic and non‐ischemic congestive heart failure2001/03/01English
Increased circulating levels of ouabain‐like factor in patients with asymptomatic left ventricular dysfunction2001/03/01English
Use of medical resources and quality of life of patients with chronic heart failure: a prospective survey in a large Italian community hospital1999/12/01English
Acute heart failure due to neoplastic invasion of ventricular myocardium by relapsing thymoma2001/01/01English
Letter to the editor1999/12/01English
Subject index1999/12/01English
Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience1999/08/01English
Does in‐patient ECG monitoring have an impact on medical care in chronic heart failure patients?2000/09/01English
Non‐invasive monitoring of pulmonary capillary wedge pressure in heart failure2001/01/01English
Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies2000/09/01English
Baseline demographics of the Valsartan Heart Failure Trial2000/12/01English
Pacing for heart failure: selection of patients, techniques and benefits1999/08/01English